Why demand is rising for secure and climate-controlled gene therapy services
Pharmaceutical Technology
JUNE 19, 2023
“Cell and gene therapies are not your typical clinical supply chain. It’s much more complex and it has to be 100% correct, or else patients are really at risk,” explains Michael MacNeir, vice president of Business Development, Sharp Clinical. That was really a key part of the design.
130 
Let's personalize your content